- Home
- APGE vs APLE Comparison
APGE vs APLE Comparison
Compare APGE & APLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- APLE
- Stock Information
- Founded
- APGE 2022
- APLE 2007
- Country
- APGE United States
- APLE United States
- Employees
- APGE N/A
- APLE N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- APLE Real Estate Investment Trusts
- Sector
- APGE Health Care
- APLE Real Estate
- Exchange
- APGE Nasdaq
- APLE Nasdaq
- Market Cap
- APGE 2.4B
- APLE 2.8B
- IPO Year
- APGE 2023
- APLE 2015
- Fundamental
- Price
- APGE $56.04
- APLE $11.40
- Analyst Decision
- APGE Strong Buy
- APLE Buy
- Analyst Count
- APGE 8
- APLE 7
- Target Price
- APGE $94.63
- APLE $14.71
- AVG Volume (30 Days)
- APGE 923.1K
- APLE 3.1M
- Earning Date
- APGE 11-12-2025
- APLE 11-03-2025
- Dividend Yield
- APGE N/A
- APLE 8.38%
- EPS Growth
- APGE N/A
- APLE N/A
- EPS
- APGE N/A
- APLE 0.76
- Revenue
- APGE N/A
- APLE $1,423,951,000.00
- Revenue This Year
- APGE N/A
- APLE $0.95
- Revenue Next Year
- APGE N/A
- APLE $2.15
- P/E Ratio
- APGE N/A
- APLE $15.16
- Revenue Growth
- APGE N/A
- APLE 2.42
- 52 Week Low
- APGE $26.20
- APLE $10.44
- 52 Week High
- APGE $63.50
- APLE $16.50
- Technical
- Relative Strength Index (RSI)
- APGE 66.05
- APLE 35.10
- Support Level
- APGE $54.80
- APLE $11.44
- Resistance Level
- APGE $57.23
- APLE $11.81
- Average True Range (ATR)
- APGE 2.61
- APLE 0.23
- MACD
- APGE -0.18
- APLE 0.01
- Stochastic Oscillator
- APGE 62.75
- APLE 53.16
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About APLE Apple Hospitality REIT Inc.
Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.